ArticleDrugs in context2025
Conservative management of paediatric dacryocystitis: a collection of clinical experiences highlighting effectiveness and parental satisfaction.
Article in Drugs in context, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Paediatric dacryocystitis, often linked to congenital nasolacrimal duct obstruction, may require surgical intervention if local conservative treatment is ineffective. This case series evaluated a local conservative treatment approach in five infants (1-12 months). Patients received Crigler massages twice daily, a 0.01% hypochlorous acid-based disinfectant spray and moxifloxacin eye drops during acute episodes. Symptoms progressively improved, with complete resolution within 6-9 months and no recurrence. The regimen was well tolerated and no surgical intervention was needed. These findings suggest that this local conservative strategy may serve as an effective first-line treatment, potentially reducing the need for invasive procedures in paediatric dacryocystitis management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.